Cellworks
Precise, Transparent, Cost-effective Personalized Cancer Care
San Jose, United States · Founded 2005 · $15.5M raised
- Headquarters
- San Jose, California
- Employees
- 51–200
- Founded
- 2005
- Business Model
- B2B
- Website
- cellworks.life
- Total Funding
- $15.5M
- Last Round
- $15.5M Series CJun 2020
About
Founded in 2005 and backed by UnitedHealth Group, Sequoia Capital, Agilent and Artiman, Cellworks has built a trans-disciplinary team of molecular biologists, cellular pathway modelers, and software technologists. The Cellworks Platform uses multi-omics modeling, computational biosimulation, and AI to predict the most efficacious therapies for individual patients — generating a Therapy Response Index (TRI) report for physicians. The platform goes beyond the one-mutation, one-drug NGS paradigm to evaluate multiple aberrations and alternative therapy options. Cellworks also assists BioPharma in improving clinical trial success rates and resurrecting failed drugs, with therapeutic focus in oncology and immunology.
Summary
Cellworks is a Biotech company based in San Jose, United States, founded in 2005. It has raised $15.5M in total, most recently a $15.5M Series C round in Jun 2020.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Funding History
No funding data available yet.
Know something? Help us improve our data.
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...